A Successful Sexual Assault Resistance Program Also Reduced Intimate Partner Violence.
Paula C BarataTanja SamardzicMisha EliasziwCharlene Y SennH Lorraine RadtkeKaren L HobdenWilfreda E ThurstonPublished in: Journal of interpersonal violence (2024)
Despite several parallels between intimate partner violence (IPV) and sexual assault (SA), programs designed to reduce either of these forms of violence against women rarely evaluate the impact on both IPV and SA. Accordingly, we investigated whether one such program (the Enhanced Assess, Acknowledge, Act (EAAA) Sexual Assault Resistance program), designed to help university-aged women resist SA, could also reduce subsequent IPV. Women university students who were enrolled in the Sexual Assault Resistance Education (SARE) randomized controlled trial examining the impact of the EAAA program on SA, were recruited immediately after completing the last survey in the SARE trial. From this trial, 153 women completed the IPV substudy, which included an additional survey. Occurrence of IPV was assessed using the Composite Abuse Scale. Of the 93 new relationships reported by 66 women in the control group, the 1-year risk of IPV was 26.8%. In contrast, of the 113 new relationships reported by 87 women in the EAAA program group, the 1-year risk of IPV was 12.2%. Effectively, the EAAA program significantly reduced the 1-year risk of IPV by 54.4% ( p = .037, 95% CI [2.9%, 79.8%]). Our findings suggest that the EAAA program is effective in reducing the risk of IPV and highlights the generalizability of programming that targets the foundational underpinning of multiple forms of gender-based violence.
Keyphrases
- intimate partner violence
- polycystic ovary syndrome
- quality improvement
- randomized controlled trial
- pregnancy outcomes
- mental health
- cervical cancer screening
- clinical trial
- breast cancer risk
- healthcare
- magnetic resonance
- pregnant women
- public health
- cross sectional
- insulin resistance
- single molecule
- contrast enhanced